[Date Prev][Date Next][Date Index]

E-M:/ Dingell, Stupak Call on Infant Formula Manufacturers to Remove Bisphenol A from Packaging



 

 

 

NEWS RELEASE

Committee on Energy and Commerce

Rep. John D. Dingell, Chairman

 

For immediate release: May 6, 2008

Contact:  Jodi Seth or Alex Haurek 202-225-5735

 

 

Dingell, Stupak Call on Infant Formula Manufacturers to Remove Bisphenol A from Packaging

 

Washington, D.C. – In the wake of heightened health concerns about Bisphenol A, two key lawmakers are calling on prominent infant formula manufacturers to discontinue use of the chemical in their packaging.  In letters to four manufacturers, Reps. John D. Dingell (D-MI), the Chairman of the Committee on Energy and Commerce, and Bart Stupak (D-MI), the Chairman of the Oversight and Investigations Subcommittee, asked the companies to stop using Bisphenol A (BPA) in their infant formula packaging. 

 

“Concerns about the health effects of Bisphenol A have mounted in recent weeks,” Dingell said.  “Given the dangers posed by this chemical and the public’s growing unease, infant formula manufacturers should play it safe and reassure parents and families by discontinuing use of this chemical.”

 

“While FDA continues its safety assessment and some retailers pull products containing BPA from their shelves, we cannot ignore the potential risk of infant formula packaging containing BPA that remains on the market,” Stupak said.  “We are asking infant formula makers to voluntarily remove BPA from their packaging in order to protect developing children from the chemical’s devastating effects.”

 

The letters were sent to: Mead Johnson & Company; Nestle USA, Inc.; PBM Products; and Ross Products Division of Abbott Labs.  Those four companies produce liquid infant formula for consumption in the United States.

 

The Committee notes that Abbott Labs has already commenced efforts to evaluate and identify alternative packaging options. “We applaud those efforts and encourage them and others to proceed expeditiously,” said Dingell.  

 

Dingell and Stupak began investigating BPA in January.  At that time, the lawmakers wrote the infant formula manufacturers to ask whether and how the companies test for Bisphenol A in their infant formula.  The lawmakers are also pressing the Food and Drug Administration about how it determined that BPA is safe. 

 

In April, the National Toxicology Program, an office within the National Institutes of Health, released a Draft Brief that suggested that the chemical may cause neural and behavioral problems as well as effects in the prostate gland, mammary gland, and an earlier age for puberty in females.  Canada recently announced plans to ban the compound.  Nalgene Outdoor Products, a manufacturer of water bottles popular with athletes, has announced plans to remove BPA from their plastic bottles and replace them with BPA-free alternatives.  Wal-Mart has said it will pull products with BPA from its shelves and replace them with BPA-free alternatives. 

 

Note: the text of the letter is below. 

 

For additional information on the Committee’s investigation into Bisphenol A, please visit: http://energycommerce.house.gov/Investigations/Bisphenol.shtml

 

May 6, 2008

 

 

Mr. Paul Bulcke

Executive Vice President

Nestlé USA, Inc.

800 North Brand Boulevard
Glendale, CA 91203

 

Dear Mr. Bulcke:

 

Under Rules X and XI of the Rules of the U.S. House of Representatives, the Committee on Energy and Commerce and its Subcommittee on Oversight and Investigations are investigating the use of Bisphenol A (BPA), particularly in products intended for use by infants and children. 

 

Thank you for your response to our letter of January 17, 2008.  Since that time, the National Toxicology Program has released a Draft Brief, which indicates that there is “some concern for neural and behavioral effects in fetuses, infants, and children at current human exposures.”  Of note is that these concerns are based on “low” level exposures, which “can cause changes in behavior and the brain, prostate gland, mammary gland, and the age at which females attain puberty.”  In summary, the brief states “the possibility that bisphenol A may alter human development cannot be dismissed.”

 

In addition, according to press reports, Health Canada will officially determine that BPA is “toxic.”  Major retailers in Canada have already begun to remove products containing BPA from their shelves. 

 

Given these determinations based on the available scientific data, we called on the U.S. Food and Drug Administration to reconsider their safety assessment of BPA on April 15, 2008.  We believe that health risks from BPA in developing infants and children are serious enough to warrant immediate action, and we are concerned that BPA remains in the packaging of your infant formula products.

 

We ask that you voluntarily remove BPA from your infant formula packaging.  We believe that this measure will help protect developing infants and children from the neural, behavioral, and developmental risks of BPA.  We also believe that such action will provide reassurance to concerned parents who might worry that their children will have altered prostate and mammary glands or reach early puberty simply because of their infant formula.

 

We ask that you respond in writing and deliver your response to the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, Room 316, Ford House Office Building, no later than two weeks from the date of this letter.  After review of your response, we may require additional records and/or staff interviews with company officers and/or employees. 

 

Thank you for your prompt attention to this matter. 

 

Sincerely,

 

 

 

           

s/John D. Dingell                                                           s/Bart Stupak

Chairman                                                                      Chairman

Committee on Energy and Commerce               Subcommittee on Oversight and Investigations

 

 

 

cc:        The Honorable Joe Barton, Ranking Member

Committee on Energy and Commerce

 

The Honorable John Shimkus, Ranking Member

Subcommittee on Oversight and Investigations

 

 

 

- 30 -